Clinical Trials Browser

Phase 2/3 × Gallbladder Neoplasms × Drug Therapy × Clear all

NCT05833815 2024-08-13

Addition of Everolimus to Standard of Care in Carcinoma Gallbladder

Phase 2/3 Recruiting

Gastrointestinal

Gallbladder Neoplasms